Tripletail Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Tripletail Wealth Management's LLY Position: Q1 2026 in Review
Tripletail Wealth Management reduced its Eli Lilly (LLY) stake by 6.8% in Q1 2026, selling an estimated $52.7K and leaving 710 shares worth $664K. The position accounts for 0.91% of the portfolio, ranked #25.
Tripletail Wealth Management first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $819K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Tripletail Wealth Management held 710 shares of Eli Lilly worth $664K as of Q1 2026.
- Tripletail Wealth Management sold 52 Eli Lilly shares in Q1 2026, an estimated $52.7K.
- Eli Lilly made up 0.91% of Tripletail Wealth Management's portfolio in Q1 2026, its #25 holding.
- Tripletail Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
- Tripletail Wealth Management's Eli Lilly position peaked at $819K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Tripletail Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.